Article info

Download PDFPDF
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease
  1. Correspondence to:
    Dr Simon Robinson
    Centre for Cardiovascular Sciences, University of Edinburgh, Royal Infirmary of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SB, UK; simon.robinson{at}ed.ac.uk
View Full Text

Citation

Robinson SD, Ludlam CA, Boon NA, et al
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease

Publication history

  • First published April 29, 2005.
Online issue publication 
January 13, 2006

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.